LONDON – On Monday, Pfizer (NYSE: PFE) won a bid in a London court to invalidate two of GSK’s (NYSE: […]
Pfizer Secures Legal Victory Against GSK in RSV Vaccine Patent Dispute Read More »
GSK (NYSE: GSK), Sanofi (NASDAQ: SNY), and CSL Ltd have secured $72 million from the U.S. government to ramp up
Sanofi, GSK, CSL Secure $72 Million Funding to Expand US Bird Flu Vaccine Supply Read More »
On Wednesday, GSK (NYSE: GSK), the British drugmaker, said it had agreed to settle two lawsuits in California that claimed
GSK (NYSE: GSK) Settles Two California Lawsuits Over Heartburn Drug Zantac Read More »
On Thursday, GSK (NYSE: GSK), the British drugmaker, announced positive results from a mid-stage trial of its seasonal influenza vaccine
GSK (NYSE: GSK) Advances mRNA Flu Vaccine to Late-Stage Trials Read More »
On Friday, British drugmaker GSK (NYSE: GSK) said it would seek a dismissal of an upcoming Zantac case in Florida,
GSK (NYSE: GSK) to Seek Dismissal of Florida Zantac Case Over Prostate Cancer Claims Read More »
FRANKFURT – On Thursday, Germany’s influential vaccine advisory panel said that everyone in the country who is 75 years old
German Panel Endorses GSK, Pfizer RSV Vaccines for 75+ Age Group Read More »
GSK (NYSE: GSK) won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on
GSK (NYSE: GSK) Scores Legal Win as Zantac Cancer Claims Falter Read More »
British drugmaker GSK (NYSE: GSK) cut its forecast for 2024 vaccine sales on Wednesday after quarterly revenue from its blockbuster
GSK (NYSE: GSK) Lowers 2024 Vaccine Sales Forecast, Stock Falls Read More »
On Wednesday, British drugmaker GSK (NYSE: GSK) bought partner CureVac (NASDAQ: CVAC) out of their alliance on influenza and COVID-19
GSK (NYSE: GSK) Acquires Full Rights to COVID and Influenza Vaccines from CureVac Read More »
